You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Carcinoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC, Carcinoma, Renal Cell, Esophageal Squamous Cell Carcinoma Trial (QEQ278)

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • +3 more
  • QEQ278
  • (no location specified)
Jul 14, 2022

Head and Neck Squamous Cell Carcinoma, PET/CT Trial (Neck dissection)

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • PET/CT
  • Neck dissection
  • (no location specified)
Jan 31, 2023

Locally Advanced Head and Neck Squamous Cell Carcinoma Trial (Toripalimab)

Not yet recruiting
  • Locally Advanced Head and Neck Squamous Cell Carcinoma
  • (no location specified)
Mar 20, 2023

Advanced Hepatocellular Carcinoma Trial in Shenzhen (GPC3 CAR-T cells)

Recruiting
  • Advanced Hepatocellular Carcinoma
  • GPC3 CAR-T cells
  • Shenzhen, Guangdong, China
    Li Yu
Nov 17, 2022

Advanced Hepatocellular Carcinoma Trial in Zhuhai (GDKM-100 injection)

Withdrawn
  • Advanced Hepatocellular Carcinoma
  • GDKM-100 injection
  • Zhuhai, Guangdong, China
    Zhuhai People'S Hospital
Jan 16, 2023

Esophageal Squamous Cell Carcinoma by AJCC V8 Stage Trial (Radiotherapy, Toripalimab)

Not yet recruiting
  • Esophageal Squamous Cell Carcinoma by AJCC V8 Stage
  • (no location specified)
Mar 17, 2023

Merkel Cell Carcinoma, Neuroendocrine Carcinoma of the Skin, Trabecular Carcinoma of the Skin Trial in Tampa (Lenvatinib Oral

Recruiting
  • Merkel Cell Carcinoma
  • +2 more
  • Tampa, Florida
    Moffitt Cancer Center
Jul 27, 2022

Key Genes in Hepatocellular Carcinoma

Recruiting
  • Hepatocellular Carcinoma
  • None of intervention
  • Hangzhou, Zhejiang, China
    2nd Affiliated Hospital, School of Medicine, Zhejiang University
Feb 26, 2023

Hepatocellular Carcinoma Trial (Irinotecan, Sonidegib, Sorafenib)

Not yet recruiting
  • Hepatocellular Carcinoma
  • (no location specified)
Dec 20, 2022

Basal Cell Carcinoma, Cutaneous Squamous Cell Carcinoma Trial in Lausanne (FLASH RT, Conventional RT)

Not yet recruiting
  • Basal Cell Carcinoma
  • Cutaneous Squamous Cell Carcinoma
  • FLASH RT
  • Conventional RT
  • Lausanne, Vaud, Switzerland
    Centre Hospitalier Universitaire Vaudois (CHUV)
Feb 13, 2023

Nasopharyngeal Carcinoma, Recurrent Cancer Trial in Guangzhou (Tranilast)

Recruiting
  • Nasopharyngeal Carcinoma
  • Recurrent Cancer
  • Guangzhou, Guangdong, China
    Southern medical university
Nov 15, 2022

Esophageal Squamous Cell Carcinoma Trial (AK104)

Not yet recruiting
  • Esophageal Squamous Cell Carcinoma
  • (no location specified)
Oct 25, 2022

Adrenal Vein Sampling asTool to Identify Biomarkers That Aid

Recruiting
  • Adrenocortical Carcinoma
  • Blood sampling.
  • Rotterdam, Netherlands
    Erasmus MC
Dec 14, 2022

Platinum-resistant Ovarian Cancer, Endometrial Adenocarcinoma, Urothelial Carcinoma Trial in Canton (ACR-368, Gemcitabine,

Recruiting
  • Platinum-resistant Ovarian Cancer
  • +2 more
  • Canton, Ohio
    Gabrail Cancer Center
Sep 16, 2022

Hepatocellular Carcinoma Trial in Hangzhou (PVE+cTACE+Camrelizumab+Apatinib, cTACE+Atirizumab+Bevacizumab)

Recruiting
  • Hepatocellular Carcinoma
  • PVE+cTACE+Camrelizumab+Apatinib
  • cTACE+Atirizumab+Bevacizumab
  • Hangzhou, Zhejiang, China
    2nd Affiliated Hospital, School of Medicine, Zhejiang University
Feb 26, 2023

Vitamin-D Receptor in Laryngeal Squamous Cell Carcinoma

Not yet recruiting
  • Laryngeal Carcinoma
    • (no location specified)
    Jan 16, 2023

    Merkel Cell Carcinoma Trial in Philadelphia (Pembrolizumab)

    Not yet recruiting
    • Merkel Cell Carcinoma
    • Philadelphia, Pennsylvania
      Penn Medicine
    Aug 9, 2022

    Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma, Kidney Cancer Trial in Boston (Implantable Microdevice (IMD))

    Not yet recruiting
    • Renal Cell Carcinoma
    • +2 more
    • Implantable Microdevice (IMD)
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    Jan 17, 2023

    Esophageal Squamous Cell Carcinoma Trial (Envafolimab, Albumin-Bound Paclitaxel, Carboplatin)

    Not yet recruiting
    • Esophageal Squamous Cell Carcinoma
    • (no location specified)
    Sep 21, 2022

    ctDNA-MRD in Predicting Efficacy of Esophageal Squamous Cell

    Not yet recruiting
    • Squamous Cell Carcinoma of Esophagus
      • (no location specified)
      Feb 25, 2023

      Galectin-3 in Papillary Thyroid Carcinoma

      Not yet recruiting
      • Galactin 3-thyroid Carcinoma
        • (no location specified)
        Jan 26, 2023

        Urothelial Carcinoma, Renal Cell Carcinoma, Melanoma Trial (BGB-A445, Tislelizumab)

        Not yet recruiting
        • Urothelial Carcinoma
        • +2 more
        • (no location specified)
        Dec 15, 2022

        Advanced Nasopharyngeal Carcinoma Trial in Hangzhou (SBRT)

        Recruiting
        • Advanced Nasopharyngeal Carcinoma
        • SBRT
        • Hangzhou, Zhejiang, China
          Zhejiang Cancer Hospital
        Dec 5, 2022

        Cutaneous Squamous Cell Carcinoma Staging Study

        Not yet recruiting
        • Cutaneous Squamous Cell Carcinoma
        • This is not an interventional study
        • (no location specified)
        Jan 20, 2023

        Frequency for Patients With Gastric Neuroendocrine Carcinoma

        Completed
        • Gastric Neuroendocrine Carcinoma
          • Fuzhou, Fujian, China
            Chang-ming Huang
          Dec 31, 2022